NDC 67296-2191 – BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC67296-2191

Product details

Brand name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Generic name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Labeler
Redpharm Drug
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA209069
Marketed since
September 1, 2020
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (2)

Package NDCDescriptionSince
67296-2191-112 TABLET in 1 BOTTLE, PLASTIC (67296-2191-1)Sep 1, 2020
67296-2191-66 TABLET in 1 BOTTLE, PLASTIC (67296-2191-6)Sep 1, 2020

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products